Metformin sensitizes hypoxia-induced gefitinib treatment resistance of HNSCC via cell cycle regulation and EMT reversal
Xiteng Yin(Nanjing University), Wei Han(Nanjing Medical University)
Cited by 26
Related Papers
Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment
|Oncotarget|2016|75
Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis
|Scientific Reports|2016|56
Multifunctional photodynamic/photothermal nano-agents for the treatment of oral leukoplakia
|Journal of Nanobiotechnology|2022|35
HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis
|BioMed Research International|2019|22